Enhancement of oral absorption in selective 5-HT1D receptor agonists:: Fluorinated 3-[3-(piperidin-1-yl)propyl]indoles

被引：25

作者：

Castro, JL

Collins, I

Russell, MGN

Watt, AP

Sohal, B

Rathbone, D

Beer, MS

Stanton, JA

机构：

[1] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Chem, Harlow CM20 2QR, Essex, England

[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Biochem, Harlow CM20 2QR, Essex, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1998年 / 41卷 / 15期

关键词：

D O I：

10.1021/jm980204e

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：2667 / 2670

页数：4

共 34 条

[1]

Bouchelet I, 1996, MOL PHARMACOL, V50, P219

[2]

BRAYDEN D, 1997, PHARM NEWS, V3, P11

[3] NEUROGENIC MODEL OF MIGRAINE [J].

BUZZI, MG ;

BONAMINI, M ;

MOSKOWITZ, MA .

CEPHALALGIA, 1995, 15 (04) :277-280

[4] 5-(piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: High-affinity, basic ligands for the cholecystokinin-B receptor [J].

Castro, JL ;

Broughton, HB ;

Russell, MGN ;

Rathbone, D ;

Watt, AP ;

Ball, RG ;

Chapman, KL ;

Patel, S ;

Smith, AJ ;

Marshall, GR ;

Matassa, VG .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (16) :2491-2501

[5] 3-[2-(pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype [J].

Castro, JL ;

Street, LJ ;

Guiblin, AR ;

Jelley, RA ;

Russell, MGN ;

Sternfeld, F ;

Beer, MS ;

Stanton, JA ;

Matassa, VG .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) :3497-3500

[6]

CASTRO JL, 1997, Patent No. 18202

[7]

Chan OH, 1996, DRUG DISCOV TODAY, V1, P461

[8]

CHUSTECKA Z, 1997, PHARMAPROJECTS M MAR, P16

[9]

CONNOR HE, 1996, MIGRAINE PHARM GENET, P18

[10]

Corey E. J., 1973, ORG SYNTH, V5, P755

← 1 2 3 4 →